ID
21490
Description
This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL); ODM derived from: https://clinicaltrials.gov/show/NCT00517218
Lien
https://clinicaltrials.gov/show/NCT00517218
Mots-clés
Versions (1)
- 24/04/2017 24/04/2017 -
Téléchargé le
24 avril 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Lymphocytic Leukemia NCT00517218
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Absolute lymphocyte count
Type de données
boolean
Alias
- UMLS CUI [1]
- C3544087
Description
Chemotherapy Chronic Lymphocytic Leukemia | Therapeutic procedure Chronic Lymphocytic Leukemia | Transplantation, Homologous
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0392920
- UMLS CUI [1,2]
- C0023434
- UMLS CUI [2,1]
- C0087111
- UMLS CUI [2,2]
- C0023434
- UMLS CUI [3]
- C0040739
Description
major surgery
Type de données
boolean
Alias
- UMLS CUI [1]
- C0679637
Description
Operative Surgical Procedures Adverse effects Serious | Recovering failed
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0879626
- UMLS CUI [1,3]
- C0205404
- UMLS CUI [2,1]
- C0521108
- UMLS CUI [2,2]
- C0231175
Description
Autoimmune hemolytic anemia | Autoimmune thrombocytopenia
Type de données
boolean
Alias
- UMLS CUI [1]
- C0002880
- UMLS CUI [2]
- C0242584
Description
Communicable Disease Serious | Anti-infective therapy Systemic Patient need for
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0009450
- UMLS CUI [1,2]
- C0205404
- UMLS CUI [2,1]
- C1141958
- UMLS CUI [2,2]
- C0205373
- UMLS CUI [2,3]
- C0686904
Similar models
Eligibility Lymphocytic Leukemia NCT00517218
- StudyEvent: Eligibility
C0332155 (UMLS CUI [1,2])
C0023434 (UMLS CUI [2,1])
C0205103 (UMLS CUI [2,2])
C1514715 (UMLS CUI [2,3])
C0023434 (UMLS CUI [3,1])
C0332167 (UMLS CUI [3,2])
C1514715 (UMLS CUI [3,3])
C0023434 (UMLS CUI [2])
C1514873 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0023434 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C0040739 (UMLS CUI [3])
C0879626 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0521108 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0242584 (UMLS CUI [2])
C0205404 (UMLS CUI [1,2])
C1141958 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])